BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 31398338)

  • 21. Identification of fructosamine residues deglycated by fructosamine-3-kinase in human hemoglobin.
    Delpierrre G; Vertommen D; Communi D; Rider MH; Van Schaftingen E
    J Biol Chem; 2004 Jun; 279(26):27613-20. PubMed ID: 15102834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nestin regulates cellular redox homeostasis in lung cancer through the Keap1-Nrf2 feedback loop.
    Wang J; Lu Q; Cai J; Wang Y; Lai X; Qiu Y; Huang Y; Ke Q; Zhang Y; Guan Y; Wu H; Wang Y; Liu X; Shi Y; Zhang K; Wang M; Peng Xiang A
    Nat Commun; 2019 Nov; 10(1):5043. PubMed ID: 31695040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different Inhibition of Nrf2 by Two Keap1 Isoforms α and β to Shape Malignant Behaviour of Human Hepatocellular Carcinoma.
    Chen F; Xiao M; Feng J; Wufur R; Liu K; Hu S; Zhang Y
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Ubiquitin E3 Ligase TRIM21 Promotes Hepatocarcinogenesis by Suppressing the p62-Keap1-Nrf2 Antioxidant Pathway.
    Wang F; Zhang Y; Shen J; Yang B; Dai W; Yan J; Maimouni S; Daguplo HQ; Coppola S; Gao Y; Wang Y; Du Z; Peng K; Liu H; Zhang Q; Tang F; Wang P; Gao S; Wang Y; Ding WX; Guo G; Wang F; Zong WX
    Cell Mol Gastroenterol Hepatol; 2021; 11(5):1369-1385. PubMed ID: 33482392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fructosamine-6-phosphates are deglycated by phosphorylation to fructosamine-3,6-bisphosphates catalyzed by fructosamine-3-kinase (FN3K) and/or fructosamine-3-kinase-related-protein (FN3KRP).
    Szwergold BS
    Med Hypotheses; 2007; 68(1):37-45. PubMed ID: 16920277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A mammalian protein homologous to fructosamine-3-kinase is a ketosamine-3-kinase acting on psicosamines and ribulosamines but not on fructosamines.
    Collard F; Delpierre G; Stroobant V; Matthijs G; Van Schaftingen E
    Diabetes; 2003 Dec; 52(12):2888-95. PubMed ID: 14633848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fumonisin B
    Arumugam T; Ghazi T; Chuturgoon AA
    Arch Toxicol; 2021 Apr; 95(4):1367-1378. PubMed ID: 33496827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation and role of nuclear factor-E2-related factor 2 (Nrf2) in multidrug resistance of hepatocellular carcinoma.
    Tian B; Lu ZN; Guo XL
    Chem Biol Interact; 2018 Jan; 280():70-76. PubMed ID: 29223570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The oncoprotein HBXIP competitively binds KEAP1 to activate NRF2 and enhance breast cancer cell growth and metastasis.
    Zhou XL; Zhu CY; Wu ZG; Guo X; Zou W
    Oncogene; 2019 May; 38(21):4028-4046. PubMed ID: 30692632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence That Differences in Fructosamine-3-Kinase Activity May Be Associated With the Glycation Gap in Human Diabetes.
    Dunmore SJ; Al-Derawi AS; Nayak AU; Narshi A; Nevill AM; Hellwig A; Majebi A; Kirkham P; Brown JE; Singh BM
    Diabetes; 2018 Jan; 67(1):131-136. PubMed ID: 29066600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NRF2 SUMOylation promotes de novo serine synthesis and maintains HCC tumorigenesis.
    Guo H; Xu J; Zheng Q; He J; Zhou W; Wang K; Huang X; Fan Q; Ma J; Cheng J; Mei W; Xing R; Cai R
    Cancer Lett; 2019 Dec; 466():39-48. PubMed ID: 31546024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of AKT pathway by Nrf2/PDGFA feedback loop contributes to HCC progression.
    Liu D; Zhang Y; Wei Y; Liu G; Liu Y; Gao Q; Zou L; Zeng W; Zhang N
    Oncotarget; 2016 Oct; 7(40):65389-65402. PubMed ID: 27588483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human fructosamine-3-kinase: purification, sequencing, substrate specificity, and evidence of activity in vivo.
    Szwergold BS; Howell S; Beisswenger PJ
    Diabetes; 2001 Sep; 50(9):2139-47. PubMed ID: 11522682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrinsic toxicity of glucose, due to non-enzymatic glycation, is controlled in-vivo by deglycation systems including: FN3K-mediated deglycation of fructosamines and transglycation of aldosamines.
    Szwergold BS
    Med Hypotheses; 2005; 65(2):337-48. PubMed ID: 15922110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GULP1 regulates the NRF2-KEAP1 signaling axis in urothelial carcinoma.
    Hayashi M; Guida E; Inokawa Y; Goldberg R; Reis LO; Ooki A; Pilli M; Sadhukhan P; Woo J; Choi W; Izumchenko E; Gonzalez LM; Marchionni L; Zhavoronkov A; Brait M; Bivalacqua T; Baras A; Netto GJ; Koch W; Singh A; Hoque MO
    Sci Signal; 2020 Aug; 13(645):. PubMed ID: 32817372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of the Nrf2 response by oleanolic acid oxime morpholide (3-hydroxyiminoolean-12-en-28-oic acid morpholide) is associated with its ability to induce apoptosis and inhibit proliferation in HepG2 hepatoma cells.
    Narożna M; Krajka-Kuźniak V; Kleszcz R; Bednarczyk-Cwynar B; Szaefer H; Baer-Dubowska W
    Eur J Pharmacol; 2020 Sep; 883():173307. PubMed ID: 32668287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of fructosamine-3-kinase deficiency on function and survival of mouse pancreatic islets after prolonged culture in high glucose or ribose concentrations.
    Pascal SM; Veiga-da-Cunha M; Gilon P; Van Schaftingen E; Jonas JC
    Am J Physiol Endocrinol Metab; 2010 Mar; 298(3):E586-96. PubMed ID: 20009024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A simple colorimetric assay for measuring fructosamine 3 kinase activity.
    Cikomola JC; Kishabongo AS; Vandepoele K; Mulder M; Katchunga PB; Laukens B; Schie LV; Grootaert H; Callewaert N; Speeckaert MM; Delanghe JR
    Clin Chem Lab Med; 2017 Jan; 55(1):154-159. PubMed ID: 27394048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis.
    Mohs A; Otto T; Schneider KM; Peltzer M; Boekschoten M; Holland CH; Hudert CA; Kalveram L; Wiegand S; Saez-Rodriguez J; Longerich T; Hengstler JG; Trautwein C
    J Hepatol; 2021 Mar; 74(3):638-648. PubMed ID: 33342543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TNFAIP2 confers cisplatin resistance in head and neck squamous cell carcinoma via KEAP1/NRF2 signaling.
    Xu T; Yang Y; Chen Z; Wang J; Wang X; Zheng Y; Wang C; Wang Y; Zhu Z; Ding X; Zhou J; Li G; Zhang H; Zhang W; Wu Y; Song X
    J Exp Clin Cancer Res; 2023 Aug; 42(1):190. PubMed ID: 37525222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.